Medtronic (MDT) Stock Rises on Earnings Beat

NEW YORK (TheStreet) -- Medtronic (MDT) shares are up 0.48% to $77.07 in early market trading on Tuesday after the medical technology company reported its fourth quarter earnings results before the opening bell today.

The company reported a fourth quarter net loss of $1 million, after reporting a profit in the year ago period, for adjusted earnings of $1.16 per share. Analysts on average were expecting the company to report earnings of $1.11 per share.

Revenue for the quarter rose 7% to $7.3 billion, also ahead of analysts' consensus $7.2 billion expectations.

The just concluded quarter was the first full quarter since the company purchased Covidien for approximately $50 billion in January.

TheStreet Ratings team rates MEDTRONIC PLC as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:

"We rate MEDTRONIC PLC (MDT) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, solid stock price performance, good cash flow from operations and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

MDT Chart MDT data by YCharts

More from Markets

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks